Synpromics' Private Equity - II Round

Synpromics raised a round of funding on April 18, 2017.

Synpromics is a developer of synthetic gene promoters, which are vital components in the research and development of gene-based medical treatments and therapies. Synpromics gives biological researcher…

Articles about Synpromics' Private Equity - II Round: